§ BIOTECHNOLOGY
USD · BiotechnologyLXEO
LEXEO THERAPEUTICS INC
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 6.2M | 0.7% | +30% |
| Affinity Asset Advisors, LLC | 5.1M | 1.5% | +58% |
| RA CAPITAL MANAGEMENT, L.P. | 5.0M | 0.3% | ±0% |
| JANUS HENDERSON GROUP PLC | 5.0M | 0.0% | +81% |
| JANUS HENDERSON GROUP PLC | 5.0M | 0.0% | n/a |
| Vestal Point Capital, LP | 4.5M | 0.7% | ±0% |
◇ AC INTELLIGENCE
Top institutional owners for LXEO as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER77.7% · 91 holders
QUALITY / COMPOUNDER15.9% · 9 holders
DEALER / BANK10.7% · 18 holders
TACTICAL / MACRO9.7% · 3 holders
PASSIVE / INDEX9.6% · 9 holders
SYSTEMATIC / QUANT0.4% · 3 holders
GROWTH / MOMENTUM0.1% · 1 holder
INCOME / DEFENSIVE0.1% · 4 holders
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for LXEO in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention LXEO yet.